project-category injections 
pharmaphorum
SEPTEMBER 21, 2022
Meanwhile, Prescript Communications – which had designed Novartis’ Kesimpta Digital Training Portal, the Bronze winner of the Internal Communications category – said that the company itself had been fortunate to undergo its own creative digitalisation makeover process before being approached for the project, having foreseen developing trends.
pharmaphorum
AUGUST 2, 2022
The results of the IMscin001 study found that an injection of Tecentriq under the skin taking just a few minutes was non-inferior to a 30 to 60-minute infusion with the IV version in terms of pharmacokinetics – how the active ingredient behaves in the body after administration. Results from a trial in first-line NSCLC are due in early 2023.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 20, 2021
The cash injection and BMS alliance have made Exscientia one of the most well-funded biotechs in the AI category and allowed it to bulk up its capabilities with the acquisition of Austrian rival Allcyte for $61 million in June.
pharmaphorum
JUNE 7, 2022
Along with bringing forward additional drugs in its pipeline, the cash injection will be used to continue development of its Pharma.AI The first quarter of 2022 is reported to be the slowest in three years for new financings in the biopharma category, coming after record levels in 2020 and 2021.
pharmaphorum
MARCH 15, 2022
Blackstone will provide €300 million in funding for the project, which will focus on a subcutaneous formulation of Sarclisa (carfilzomib) that is due to start a pivotal study later this year. Sanofi has partnered with drug delivery specialist Enable Injections to develop the subcutaneous formulation.
pharmaphorum
MARCH 16, 2021
It’s one of the few AI drug discovery companies operating in the antibody category, as most are focused on small molecules. The Cardiff, Wales startup is combining machine learning and phage display techniques to model antibody-antigen binding and says it can cut the time it takes to develop a drug candidate.
pharmaphorum
NOVEMBER 3, 2022
Another study called EAGLE-1 is comparing two oral doses of gepotidacin to a regimen based on an intramuscular injection of ceftriaxone and oral azithromycin in the treatment of urogenital gonorrhoea. There are real concerns that we could be entering a post-antibiotic era, where even minor infections can be enough to kill patients.
Expert insights. Personalized for you.
78 
Let's personalize your content